Foresight Acquisition Corp.

Foresight Acquisition Corp.

FORE
Foresight Acquisition Corp.US flagNASDAQ Global Select
9.48
USD
+0.42
- -
2.31BMarket Cap
No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

APIChat
CEO
Michael P. Balkin
Sector
Financial Services
Industry
Shell Companies
Address
233 North Michigan Avenue Chicago IL United States of America 60601
IPO Date
Apr 5, 2021
Business
Foresight Acquisition Corp. (FORE) is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It has not identified any specific target and focuses on opportunities across various sectors, including technology, healthcare, and consumer industries. The company offers no current products or services beyond its standard special purpose acquisition company (SPAC) structure, which includes units comprising Class A ordinary shares and warrants traded on Nasdaq. Incorporated in 2020 and headquartered in New York, New York, Foresight Acquisition Corp. primarily targets businesses in the United States and select international markets. No recent major changes, such as partnerships, acquisitions, funding rounds, or strategic shifts, have been publicly reported for the company within the last 1-2 years.

Company News

APIChat
  • FORE Biotherapeutics to Participate in the Wells Fargo Virtual Private Biotech Symposium

  • P3 Health Partners Announces November Conference Schedule and Virtual Investor Day in Advance of Planned Closing of Business Combination with Foresight Acquisition Corp.

  • P3 Health Partners Sets September 2021 Virtual Conference Schedule

  • Moore Kuehn Encourages FMBI, LWAC, LEGO and FORE Investors to Contact Law Firm

  • SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Foresight Acquisition Corp. - FORE